Keywords: european, countries, approve, copaxone, teva, pharmaceutiocal, glatiramer
15 European countries approve Copaxone
Article | 08 August 2001
Teva Pharmaceutiocal's Copaxone (glatiramer acetate), the first Europeanlaunch of which was in the UK last year (Marketletter December 11, 2000), has been ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
